Analyzing IBM's Decline in Today's Stock Market

After this afternoon's -1.2% drop to $172.83 per share, International Business Machines might just keep moving past its target price of $181.05. With an average analyst rating of buy, and target prices from $130.0 to $215.0, the stock's next move is anyone's guess.

The stock has an average amount of shares sold short at 2.2%, and a short ratio of 4.27. The company's insiders own 0.11% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that an average number of institutional investors are invested in the stock, with 61.5% of International Business Machines's shares being owned by this investor type.

Institutions Invested in International Business Machines

Date Reported Holder Percentage Shares Value
2024-03-31 Vanguard Group Inc 10% 88,152,714 $15,235,441,792
2024-03-31 Blackrock Inc. 8% 75,103,070 $12,980,070,601
2024-03-31 State Street Corporation 6% 54,494,085 $9,418,217,799
2024-03-31 Geode Capital Management, LLC 2% 19,810,952 $3,423,928,684
2024-03-31 Bank of America Corporation 2% 16,355,044 $2,826,643,781
2024-03-31 Morgan Stanley 2% 14,168,806 $2,448,796,064
2024-03-31 Northern Trust Corporation 1% 9,291,918 $1,605,923,055
2024-03-31 Amundi 1% 9,218,499 $1,593,234,043
2024-03-31 Bank Of New York Mellon Corporation 1% 8,748,818 $1,512,059,031
2024-03-31 Legal & General Group PLC 1% 8,042,808 $1,390,039,257

Besides an analyst consensus of some upside potential, other market factors point to there being mixed market sentiment on International Business Machines.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.